Aptose Biosciences Inc.
Hedge Funds Holdings
Last updated:
Aptose Biosciences Inc.‘s stocks are currently a part of 29 hedge funds’ portfolios, which represents 100% of the total amount of its stocks outstanding. This makes up a total of 5.33M shares of Aptose Biosciences Inc.. Compared to the previous quarter, the number fell by -76.91% or -17.78M shares fewer. As for the holding position changes, 17.24% (5) of current hedge fund investors increased the number of shares held, 24.14% (7) of current holders sold a part of the shares held, and 10.34% (3) closed the holdings completely. 1 hedge funds are new holders of Aptose Biosciences Inc. stock in Q1 2023, it is 3.45% of total holders.
Hedge funds holding Aptose Biosciences (Q2 2018 – Q1 2023)
| Q2 2018 | 21 |
|---|---|
| Q3 2018 | 16 |
| Q4 2018 | 19 |
| Q1 2019 | 21 |
| Q2 2019 | 29 |
| Q3 2019 | 30 |
| Q4 2019 | 57 |
| Q1 2020 | 52 |
| Q2 2020 | 57 |
| Q3 2020 | 64 |
| Q4 2020 | 64 |
| Q1 2021 | 70 |
| Q2 2021 | 63 |
| Q3 2021 | 63 |
| Q4 2021 | 56 |
| Q1 2022 | 49 |
| Q2 2022 | 46 |
| Q3 2022 | 46 |
| Q4 2022 | 48 |
| Q1 2023 | 29 |
Hedge funds changes in Aptose Biosciences positions (Q2 2018 – Q1 2023)
| Q2 2018 | 8 | 5 | 4 | 2 | 2 |
|---|---|---|---|---|---|
| Q3 2018 | 2 | 6 | 5 | 7 | -4 |
| Q4 2018 | 5 | 3 | 5 | 3 | 3 |
| Q1 2019 | 6 | 7 | 4 | 4 | 0 |
| Q2 2019 | 13 | 9 | 3 | 5 | -1 |
| Q3 2019 | 9 | 13 | 4 | 8 | -4 |
| Q4 2019 | 35 | 11 | 8 | 8 | -5 |
| Q1 2020 | 18 | 18 | 11 | 21 | -16 |
| Q2 2020 | 13 | 17 | 19 | 8 | 0 |
| Q3 2020 | 15 | 32 | 10 | 8 | -1 |
| Q4 2020 | 18 | 17 | 18 | 17 | -6 |
| Q1 2021 | 18 | 21 | 19 | 11 | 1 |
| Q2 2021 | 10 | 18 | 17 | 17 | 1 |
| Q3 2021 | 11 | 23 | 19 | 11 | -1 |
| Q4 2021 | 10 | 21 | 14 | 17 | -6 |
| Q1 2022 | 7 | 11 | 14 | 14 | 3 |
| Q2 2022 | 6 | 7 | 12 | 9 | 12 |
| Q3 2022 | 6 | 11 | 11 | 4 | 14 |
| Q4 2022 | 10 | 13 | 10 | 9 | 6 |
| Q1 2023 | 1 | 5 | 7 | 3 | 13 |
Hedge funds changes in Aptose Biosciences stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 69,000 | 0 |
| Q4 2018 | 22,000 | 0 |
| Q1 2019 | 50,000 | 0 |
| Q2 2019 | 5,000 | 130,000 |
| Q3 2019 | 2,000 | 251,000 |
| Q4 2019 | 1,414,000 | 918,000 |
| Q1 2020 | 578,000 | 1,301,000 |
| Q2 2020 | 507,000 | 203,000 |
| Q3 2020 | 1,546,000 | 135,000 |
| Q4 2020 | 2,494,000 | 463,000 |
| Q1 2021 | 2,689,000 | 1,372,000 |
| Q2 2021 | 447,000 | 516,000 |
| Q3 2021 | 251,000 | 370,000 |
| Q4 2021 | 197,000 | 102,000 |
| Q1 2022 | 269,000 | 25,000 |
| Q2 2022 | 158,000 | 6,000 |
| Q3 2022 | 38,000 | 10,000 |
| Q4 2022 | 31,840 | 0 |
| Q1 2023 | 0 | 0 |